ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Ambiopharm, INC.

Official 2024 U.S. DOL Form 5500 summary for Ambiopharm, INC. (Ambiopharm, INC. 401(k) Plan · EIN 22-3940281 · PN 001): $6.94M net assets, 146 active participants, and $87.67 per $10,000 (87.67 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorAmbiopharm, INC.
Filing IdentifierAmbiopharm, INC. 401(k) Plan · EIN 22-3940281 · PN 001
Plan Category & State401(k) Defined Contribution (SC)
Asset-Size Peer Cohort$5M-$25M
Plan Net Assets (2024)$6.94M
Active Participants146
Direct Admin Fee Rate$87.67 per $10,000 (87.67 bps)
Cohort Peer Median$37.06 per $10,000 (37.06 bps)
Primary Recordkeeper / ProviderTransamerica
Schedule H Line 4a RemittanceSchedule H Line 4a Late Remittance Reported ($43,416, often administrative timing)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI